Related Experiment Video

Updated: Aug 18, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Host defense peptides as new weapons in cancer treatment

N Papo1, Y Shai

  • 1Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.

Cellular and Molecular Life Sciences : CMLS
|May 4, 2005
PubMed

Insights

Antimicrobial peptides show potential as cancer treatments by disrupting cell membranes. Further research is exploring their specific anticancer activity and mechanisms for clinical use.

Area of Science:

  • Immunology
  • Biochemistry
  • Oncology

Background:

  • Innate immunity host defense peptides, also known as antimicrobial peptides (AMPs), are crucial for cellular defense.
  • AMPs can kill prokaryotic and eukaryotic cells, often by damaging cell membranes.
  • The specific mechanisms and cancer cell susceptibility to AMPs remain under investigation.

Purpose of the Study:

  • To explore the role of host defense peptides in killing cancer cells.
  • To elucidate the molecular mechanisms behind AMPs' anticancer activities.
  • To identify promising anticancer peptides with clinical potential.

Main Methods:

  • Review of existing research on antimicrobial peptides and their interaction with cell membranes.
  • Analysis of proposed mechanisms including plasma and mitochondrial membrane disruption.
  • Evaluation of studies focusing on peptide stability and specificity for cancer treatment.

Main Results:

  • Antimicrobial peptides exhibit anticancer properties through membrane disruption and apoptosis induction.
  • Cancer cells display differential susceptibility to certain AMPs.
  • New research indicates promising anticancer peptides with novel mechanisms and broad activity.

Conclusions:

  • Host defense peptides represent a potential therapeutic strategy against cancer.
  • Understanding AMPs' mechanisms of action is key to developing effective cancer treatments.
  • Further development is needed to ensure clinical applicability, focusing on specificity and stability.

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...